Work

Notes from the field: rotavirus vaccine administration errors--United States, 2006-2013.

Year: 2014
Type: article
Abstract: Two live rotavirus oral vaccines, RotaTeq (RV5) (Merck & Co., Inc.) and Rotarix (RV1) (GlaxoSmithKline Biologicals), are approved for prevention of rotavirus gastroenteritis and recommended at ages 2, 4 (RV5/RV1), and 6 (RV5) months by the Advisory Committee on Immunization Practices. Because most childhood vaccines are injectable, vaccination providers might have less experience administering oral vaccines. To assess that hypothesis, CDC searched for reports to the Vaccine Adverse Event Reporting System (VAERS) of rotavirus vaccine administration errors involving injection and eye splashes in the United States during the period January 1, 2006-August 1, 2013. A total of 66 reports were found.
Language: English
Subfield: Toxicology
Open Access status: green
OpenAlex ID: W2806444484
FWCI: 1.522
Cites: 3
Cited by: 19
Related to: 10